MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number - PubMed (original) (raw)
MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number
Hsiao-Tuan Chao et al. Neuron. 2007.
Abstract
MeCP2 is a transcriptional repressor critical for normal neurological function. Prior studies demonstrated that either loss or doubling of MeCP2 results in postnatal neurodevelopmental disorders. To understand the impact of MeCP2 expression on neuronal function, we studied the synaptic properties of individual neurons from mice that either lack or express twice the normal levels of MeCP2. Hippocampal glutamatergic neurons that lack MeCP2 display a 46% reduction in synaptic response, whereas neurons with doubling of MeCP2 exhibit a 2-fold enhancement in synaptic response. Further analysis shows that these changes were primarily due to the number of synapses formed. These results reveal that MeCP2 is a key rate-limiting factor in regulating glutamatergic synapse formation in early postnatal development and that changes in excitatory synaptic strength may underlie global network alterations in neurological disorders due to altered MeCP2 levels.
Figures
Figure 1. Loss or doubling of MeCP2 alter the magnitude of evoked EPSCs and frequency of spontaneous mEPSC events
(A) Mean action potential evoked EPSC trace from data shown in (B, C). Data collected at an earlier time point for Mecp2Tg1 neurons to reduce voltage clamp errors. (B, C) Bar graphs show EPSC amplitude. (D) Representative mEPSC traces with upper trace in the presence of 3 mM glutamate receptor blocker, kynurenic acid (Kyn). (E, F) Bar graphs show mEPSC frequency. Number of neurons analyzed (n) shown in the bars. Data shown as mean ± SEM. ** P<0.01, *** P<0.001
Figure 2. Loss or doubling of MeCP2 alter the magnitude of the RRP, without altering short-term plasticity and synaptic release probability
(A, B) Average current response to 4 s application of sucrose from data shown in (C, D). (C–F) Bar graphs show RRP size (C, D) and Pvr (E, F). Number of neurons analyzed (n) shown in the bars. (G, H) Normalized EPSC amplitude with train stimulation. (I, J) Normalized NMDA-EPSC amplitude with 5 µM MK801. Data shown as mean ± SEM. ** P<0.01, *** P<0.001
Figure 3. MeCP2 regulates glutamatergic synapse numbers
(A, B) Representative images of autaptic neurons show colocalization between MAP2 (green) and VGLUT1 (A, blue) or PSD95 (B, blue). Scale bar equals 10 µm. (C) Bar graph shows synaptic density of each marker normalized to WT (dotted line). (D) Representative images showing colocalization of VGLUT1 (blue) and PSD95 (red), arrowheads, with MAP2 (green). Scale bar equals 5 µm. (E–G) Bar graphs show fraction of colocalization for PSD95 (E) and VGLUT1 (F), and synaptic density of VGLUT1-PSD95 colocalized puncta (G). Number of neurons analyzed (n) shown in the bars is the same for WT and corresponding group. Data shown as mean ± SEM normalized to WT (dotted line). * P<0.05, ** P<0.01, *** P<0.001
Figure 4. Physiological and morphological phenotypes are restored in Mecp2Null;Tg1
(A) Bar graph shows EPSC amplitude, RRP charge and Pvr (WT, _n_=65) and mEPSC frequency, amplitude, and decay (WT, _n_=48) normalized to WT (dotted line). (B) Representative images showing colocalization of VGLUT1 (blue) and PSD95 (red), arrowheads, with MAP2 (green). Scale bar equals 5 µm. (C–E) Bar graphs show fraction of colocalization for PSD95 (C) and VGLUT1 (D), and synaptic density of VGLUT1-PSD95 colocalized puncta (E). Number of neurons (n) shown in the bars. Data shown as mean ± SEM.
Figure 5. Loss of and doubling of MeCP2 levels lead to in vivo alterations in synapse numbers in stratum radiation of hippocampal CA1
(A, B) Representative images of hippocampal CA1 show MAP2 (red) and VGLUT1 (blue) at 2 weeks of age. Scale bar equals 50 µm. Or = stratum oriens. Pyr = stratum pyramidale. Rad = stratum radiatum. (C, D) Graphs show VGLUT1 intensity in Rad. (E) Bar graph shows VGLUT1 intensity normalized to WT (dotted line). (F, G) Graphs show MAP2 intensity in Rad. (H) Bar graph shows MAP2 intensity normalized to WT (dotted line). Number of sections analyzed (n) for bar graphs is shown in corresponding graphs. Data shown as mean ± SEM. * P<0.05, ** P<0.01, *** P<0.001
Similar articles
- Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors.
Lozada AF, Wang X, Gounko NV, Massey KA, Duan J, Liu Z, Berg DK. Lozada AF, et al. J Neurosci. 2012 May 30;32(22):7651-61. doi: 10.1523/JNEUROSCI.6246-11.2012. J Neurosci. 2012. PMID: 22649244 Free PMC article. - Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons.
Basavarajappa BS, Ninan I, Arancio O. Basavarajappa BS, et al. J Neurochem. 2008 Nov;107(4):1001-13. doi: 10.1111/j.1471-4159.2008.05685.x. Epub 2008 Sep 15. J Neurochem. 2008. PMID: 18796007 Free PMC article. - Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory.
Li H, Zhong X, Chau KF, Williams EC, Chang Q. Li H, et al. Nat Neurosci. 2011 Jul 17;14(8):1001-8. doi: 10.1038/nn.2866. Nat Neurosci. 2011. PMID: 21765426 Free PMC article. - A critical and cell-autonomous role for MeCP2 in synaptic scaling up.
Blackman MP, Djukic B, Nelson SB, Turrigiano GG. Blackman MP, et al. J Neurosci. 2012 Sep 26;32(39):13529-36. doi: 10.1523/JNEUROSCI.3077-12.2012. J Neurosci. 2012. PMID: 23015442 Free PMC article. - The role of selected postsynaptic scaffolding proteins at glutamatergic synapses in autism-related animal models.
Meliskova V, Havranek T, Bacova Z, Bakos J. Meliskova V, et al. J Integr Neurosci. 2021 Dec 30;20(4):1047-1057. doi: 10.31083/j.jin2004106. J Integr Neurosci. 2021. PMID: 34997728 Review.
Cited by
- Human microglial cells as a therapeutic target in a neurodevelopmental disease model.
Mesci P, LaRock CN, Jeziorski JJ, Nakashima H, Chermont N, Ferrasa A, Herai RH, Ozaki T, Saleh A, Snethlage CE, Sanchez S, Goldberg G, Trujillo CA, Nakashima K, Nizet V, Muotri AR. Mesci P, et al. Stem Cell Reports. 2024 Aug 13;19(8):1074-1091. doi: 10.1016/j.stemcr.2024.06.013. Epub 2024 Jul 25. Stem Cell Reports. 2024. PMID: 39059378 Free PMC article. - Increased number of excitatory synapsis and decreased number of inhibitory synapsis in the prefrontal cortex in autism.
Vakilzadeh G, Maseko BC, Bartely TD, McLennan YA, Martínez-Cerdeño V. Vakilzadeh G, et al. Cereb Cortex. 2024 May 2;34(13):121-128. doi: 10.1093/cercor/bhad268. Cereb Cortex. 2024. PMID: 38696601 - Exercise epigenetics is fueled by cell bioenergetics: Supporting role on brain plasticity and cognition.
Gomez-Pinilla F, Thapak P. Gomez-Pinilla F, et al. Free Radic Biol Med. 2024 Aug 1;220:43-55. doi: 10.1016/j.freeradbiomed.2024.04.237. Epub 2024 Apr 25. Free Radic Biol Med. 2024. PMID: 38677488 Review. - IL-1β, the first piece to the puzzle of sepsis-related cognitive impairment?
Zhu Q, Wan L, Huang H, Liao Z. Zhu Q, et al. Front Neurosci. 2024 Apr 11;18:1370406. doi: 10.3389/fnins.2024.1370406. eCollection 2024. Front Neurosci. 2024. PMID: 38665289 Free PMC article. Review. - Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials.
Lopes AG, Loganathan SK, Caliaperumal J. Lopes AG, et al. Brain Sci. 2024 Jan 24;14(2):120. doi: 10.3390/brainsci14020120. Brain Sci. 2024. PMID: 38391695 Free PMC article. Review.
References
- Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188. - PubMed
- Armstrong D, Dunn JK, Antalffy B, Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol. 1995;54:195–201. - PubMed
- Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis. 2006;21:217–227. - PubMed
- Belichenko PV, Hagberg B, Dahlstrom A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol (Berl) 1997;93:50–61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases